HIGHLIGHTS
- who: Mutagenesis et al. from the Swansea University Medical School, Swansea University, Singleton Park, Swansea, United Kingdom have published the research work: Measuring blood cell DNA damage using the PIG-A mutation and CBMN assay in pancreatic cancer patients: a pilot study, in the Journal: (JOURNAL)
- what: The authors explored the human erythrocyte PIG-A assay in a cohort of patients with PC, patients with benign pancreatic disease and healthy donors. The authors aimed to determine whether the addition of DNA mutation and DNA damage markers would also improve upon current markers for PC.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.